Next, to support these findings and discard unspecific effects of the pharmacological autophagy inhibitor, CQ, we performed a knockdown of the autophagy-related protein ATG5 in two breast cancer cell lines: MCF-7 hormone receptor-positive cells and MDA-MB-231 triple-negative cells. Here, ATG5 is linked to breast cancer.